首页/数据集/Supplementary Figure 2. Time from hospital discharge to initiation of biologics, stratifying for admitting service.

Supplementary Figure 2. Time from hospital discharge to initiation of biologics, stratifying for admitting service.

Name: Supplementary Figure 2. Time from hospital discharge to initiation of biologics, stratifying for admitting service.
Creator: University of Miami School of Medicine; Larkin Community Hospital
Published: 2026-04-09T12:27:02+08:00

Mendeley Data2026-04-09 收录

化脓性汗腺炎治疗

生物制剂用药时机

数据链接：

https://data.mendeley.com/datasets/cnwtx3v84f/1 数据链接链接失效反馈

官方服务：

资源简介：

Inpatient Management of Hidradenitis Suppurativa: A Single-Center Retrospective Study

应用场景：

提供机构：

University of Miami School of Medicine; Larkin Community Hospital

相关数据集

Supplemental material

化脓性汗腺炎治疗

生物制剂疗效评估

Supplemental material to: Adalimumab in conjunction with surgery compared with adalimumab monotherapy for Hidradenitis Suppurativa; a randomized controlled trial in a real-world setting

NIAID Data Ecosystem130

Wide Local Excision is Non-inferior to Deroofing for Advanced Hidradenitis Suppurativa: A Retrospective Cohort Study

化脓性汗腺炎治疗

手术效果比较

Supplemental Material - Wide Local Excision is Non-inferior to Deroofing for Advanced Hidradenitis Suppurativa: A Retrospective Cohort Study

DataCite Commons2026-03-31 更新30

Supplementary Material for Glucagon-Like Peptide-1 Receptor Agonists Are Associated With Reduced Disease Severity and Pain in Hidradenitis Suppurativa: A Retrospective Study

药物疗效评估

化脓性汗腺炎治疗

PDF of Supplementary Material #1) Supplementary Figure: Flow Chart Documentation of Reasoning for Patient Exclusion #2) Supplementary Table: Comparison of HS-Related Medications Before and After GLP-1

NIAID Data Ecosystem20

sj-xlsx-4-cms-10.1177_12034754241230693 – Supplemental material for Safety and Efficacy of Interleukin-1β Inhibitors for Hidradenitis Suppurativa: A Systematic Review

皮肤病

化脓性汗腺炎治疗

Supplemental material, sj-xlsx-4-cms-10.1177_12034754241230693 for Safety and Efficacy of Interleukin-1β Inhibitors for Hidradenitis Suppurativa: A Systematic Review by Emmanuel Suntres, Daud Manzar a

DataCite Commons2024-08-28 更新50

Efficacy and Safety of Ruxolitinib Cream in Patients With Mild to Moderate Hidradenitis Suppurativa: Results From a Randomized, Double-Blind, Vehicle-Controlled Phase 2 Study

化脓性汗腺炎治疗

皮肤病

Supplemental data for an article published in the Journal of the American Academy of Dermatology

NIAID Data Ecosystem20